US Stock MarketDetailed Quotes

DWTX Dogwood Therapeutics

Watchlist
  • 2.710
  • +0.280+11.52%
Close Nov 21 16:00 ET
  • 2.950
  • +0.240+8.86%
Post 20:01 ET
3.61MMarket Cap-428P/E (TTM)

Dogwood Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
80.58%2.3M
-27.58%1.07M
-15.62%1.31M
-55.77%5.45M
-45.54%1.14M
-50.84%1.27M
-59.77%1.48M
-60.69%1.56M
-21.26%12.32M
-50.10%2.09M
Selling and administrative expenses
96.20%1.77M
-20.19%733.74K
-8.42%970.38K
-12.41%3.72M
2.67%839.81K
-7.20%900.09K
-27.36%919.37K
-11.12%1.06M
-12.37%4.25M
-35.55%818K
-General and administrative expense
96.20%1.77M
-20.19%733.74K
-8.42%970.38K
-12.41%3.72M
2.67%839.81K
-7.20%900.09K
-27.36%919.37K
-11.12%1.06M
-12.37%4.25M
-35.55%818K
Research and development costs
43.01%535.16K
-39.75%336.08K
-30.94%343.72K
-78.59%1.73M
-76.54%298.32K
-76.94%374.2K
-76.82%557.84K
-82.03%497.71K
-25.25%8.07M
-56.42%1.27M
Operating profit
-80.58%-2.3M
27.58%-1.07M
15.62%-1.31M
55.77%-5.45M
45.54%-1.14M
50.84%-1.27M
59.77%-1.48M
60.69%-1.56M
21.26%-12.32M
50.10%-2.09M
Net non-operating interest income expense
-47.75%20.49K
-44.95%19.99K
-43.68%22.77K
123.64%150.9K
-22.60%34.95K
136.16%39.22K
655.89%36.31K
40.42K
1,089.62%67.48K
3,464.33%45.16K
Non-operating interest income
-47.75%20.49K
-44.95%19.99K
-43.68%22.77K
123.64%150.9K
-22.60%34.95K
136.16%39.22K
655.89%36.31K
--40.42K
--67.48K
--45.16K
Other net income (expense)
Income before tax
-84.66%-2.28M
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-84.66%-2.28M
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
Net income continuous Operations
-84.66%-2.28M
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
Minority interest income
Net income attributable to the parent company
-84.66%-2.28M
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-84.66%-2.28M
27.14%-1.05M
14.87%-1.29M
56.76%-5.3M
46.04%-1.1M
52.05%-1.24M
60.71%-1.44M
61.70%-1.52M
23.26%-12.25M
54.68%-2.04M
Basic earnings per share
-26.54%-2.05
37.50%-1.25
12.50%-1.75
74.77%-7
45.45%-1.5
76.86%-1.62
81.82%-2
83.33%-2
42.19%-27.75
79.63%-2.75
Diluted earnings per share
-26.54%-2.05
37.50%-1.25
12.50%-1.75
74.77%-7
45.45%-1.5
76.86%-1.62
81.82%-2
83.33%-2
42.19%-27.75
79.63%-2.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 80.58%2.3M-27.58%1.07M-15.62%1.31M-55.77%5.45M-45.54%1.14M-50.84%1.27M-59.77%1.48M-60.69%1.56M-21.26%12.32M-50.10%2.09M
Selling and administrative expenses 96.20%1.77M-20.19%733.74K-8.42%970.38K-12.41%3.72M2.67%839.81K-7.20%900.09K-27.36%919.37K-11.12%1.06M-12.37%4.25M-35.55%818K
-General and administrative expense 96.20%1.77M-20.19%733.74K-8.42%970.38K-12.41%3.72M2.67%839.81K-7.20%900.09K-27.36%919.37K-11.12%1.06M-12.37%4.25M-35.55%818K
Research and development costs 43.01%535.16K-39.75%336.08K-30.94%343.72K-78.59%1.73M-76.54%298.32K-76.94%374.2K-76.82%557.84K-82.03%497.71K-25.25%8.07M-56.42%1.27M
Operating profit -80.58%-2.3M27.58%-1.07M15.62%-1.31M55.77%-5.45M45.54%-1.14M50.84%-1.27M59.77%-1.48M60.69%-1.56M21.26%-12.32M50.10%-2.09M
Net non-operating interest income expense -47.75%20.49K-44.95%19.99K-43.68%22.77K123.64%150.9K-22.60%34.95K136.16%39.22K655.89%36.31K40.42K1,089.62%67.48K3,464.33%45.16K
Non-operating interest income -47.75%20.49K-44.95%19.99K-43.68%22.77K123.64%150.9K-22.60%34.95K136.16%39.22K655.89%36.31K--40.42K--67.48K--45.16K
Other net income (expense)
Income before tax -84.66%-2.28M27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M
Income tax 0000000000
Net income -84.66%-2.28M27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M
Net income continuous Operations -84.66%-2.28M27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M
Minority interest income
Net income attributable to the parent company -84.66%-2.28M27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -84.66%-2.28M27.14%-1.05M14.87%-1.29M56.76%-5.3M46.04%-1.1M52.05%-1.24M60.71%-1.44M61.70%-1.52M23.26%-12.25M54.68%-2.04M
Basic earnings per share -26.54%-2.0537.50%-1.2512.50%-1.7574.77%-745.45%-1.576.86%-1.6281.82%-283.33%-242.19%-27.7579.63%-2.75
Diluted earnings per share -26.54%-2.0537.50%-1.2512.50%-1.7574.77%-745.45%-1.576.86%-1.6281.82%-283.33%-242.19%-27.7579.63%-2.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data